Aytu Biopharma, Inc.
AYTU
$2.13
-$0.05-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.03M | 32.63M | 30.95M | 18.17M | 20.40M |
| Total Receivables | 30.92M | 33.23M | 31.16M | 35.83M | 25.40M |
| Inventory | 8.66M | 10.10M | 11.43M | 11.06M | 11.09M |
| Prepaid Expenses | 6.64M | 5.15M | 5.64M | 7.46M | 6.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 76.24M | 81.11M | 79.18M | 72.51M | 63.05M |
|
|
|||||
| Total Current Assets | 76.24M | 81.11M | 79.18M | 72.51M | 63.05M |
| Net Property, Plant & Equipment | 1.44M | 1.51M | 1.59M | 1.66M | 1.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 43.58M | 41.43M | 42.20M | 48.71M | 49.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 738.00K | 939.00K | 1.20M | 1.32M | 1.52M |
| Total Assets | 122.00M | 124.99M | 124.18M | 124.20M | 116.23M |
|
|
|||||
| Total Accounts Payable | 14.26M | 12.34M | 10.60M | 12.04M | 11.70M |
| Total Accrued Expenses | 16.61M | 16.25M | 15.26M | 17.68M | 19.75M |
| Short-term Debt | 9.08M | 14.87M | 9.06M | 10.03M | 4.01M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.06M | 2.06M | 1.99M | 1.96M | 2.04M |
| Total Finance Division Other Current Liabilities | 23.57M | 20.47M | 26.15M | 29.00M | 26.54M |
| Total Other Current Liabilities | 23.57M | 20.47M | 26.15M | 29.00M | 26.54M |
| Total Current Liabilities | 65.56M | 65.99M | 63.06M | 70.71M | 64.05M |
|
|
|||||
| Total Current Liabilities | 65.56M | 65.99M | 63.06M | 70.71M | 64.05M |
| Long-Term Debt | 10.00M | 10.45M | 10.90M | 9.54M | 9.98M |
| Short-term Debt | 9.08M | 14.87M | 9.06M | 10.03M | 4.01M |
| Capital Leases | 973.00K | 1.02M | 985.00K | 1.00M | 1.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.27M | 24.35M | 30.27M | 8.06M | 10.33M |
| Total Liabilities | 107.80M | 101.82M | 105.21M | 89.30M | 85.46M |
|
|
|||||
| Common Stock & APIC | 356.36M | 354.74M | 352.50M | 348.62M | 348.48M |
| Retained Earnings | -342.15M | -331.57M | -333.54M | -313.72M | -317.71M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14.20M | 23.17M | 18.97M | 34.90M | 30.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.20M | 23.17M | 18.97M | 34.90M | 30.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.20M | 23.17M | 18.97M | 34.90M | 30.77M |
|
|
|||||